ClassID:

95252

C07D403/12 - page 15 - CPC Classification

Classification description:

Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a chain containing hetero atoms as chain links

Recent Application in this class:
#4201
20140336208
2014-11-13

1,4,5,6-TETRAHYDRO-PYRIMIDIN-2-YLAMINE COMPOUNDS

#4202
20140336170
2014-11-13

Indazole compounds useful as ketohexokinase inhibitors

#4203
20140336165
2014-11-13

Dihydroxy aromatic heterocyclic compound

#4204
20140334027
2014-11-13

Oxime ester photoinitiators

#4205
20140330010
2014-11-06

Phenylpyrrole derivative

#4206
20140330007
2014-11-06

2,4-pyrimidinediamine compounds and their uses

#4207
20140329852
2014-11-06

N—(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors

#4208
20140329819
2014-11-06

Insecticidal triazinone derivatives

#4209
20140329815
2014-11-06

Inhibitors of c-fms kinase

#4210
20140329799
2014-11-06

Aminopyrimidinones as interleukin receptor-associated kinase inhibitors

#4211
20140329798
2014-11-06

Substituted cyclopropyl compounds useful as GPR119 agonists

#4212
20140329795
2014-11-06

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#4213
20140323740
2014-10-30

IDO inhibitors

#4214
20140323499
2014-10-30

Substituted pyridines as P2Xand P2X antagonists

#4215
20140323488
2014-10-30

DISUBSTITUTED TRIAZINE DIMERS FOR TREATMENT AND/OR PREVENTION OF INFECTIOUS DISEASES

#4216
20140323485
2014-10-30

N-substituted heterocyclyl carboxamides

#4217
20140323484
2014-10-30

Pharmaceutically active pyrazine derivatives

#4218
20140323470
2014-10-30

Kinase inhibitors

#4219
20140323465
2014-10-30

HCV protease inhibitors and uses thereof

#4220
20140323464
2014-10-30

Kinase inhibitors

#4221
20140323463
2014-10-30

Pyrazinecarboxamide compound

#4222
20140323418
2014-10-30

SELECTIVE KINASE INHIBITORS

#4223
20140322247
2014-10-30

Cell proliferation inhibitors and conjugates thereof

#4224
20140316132
2014-10-23

Modulators of toll-like receptors

#4225
20140315887
2014-10-23

PYRIMIDYL CYCLOPENTANES AS AKT PROTEIN KINASE INHIBITORS

#4226
20140315721
2014-10-23

Pesticidal compositions and processes related thereto

#4227
20140314785
2014-10-23

Compositions and methods for inhibition of the JAK pathway

#4228
20140309259
2014-10-16

Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents

#4229
20140309245
2014-10-16

Heterocyclic carboxamides as modulators of kinase activity

#4230
20140309240
2014-10-16

Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents

#4231
20140309210
2014-10-16

INDAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

#4232
20140309209
2014-10-16

Pyrazine kinase inhibitors

#4233
20140309206
2014-10-16

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#4234
20140309185
2014-10-16

Inhibiting G protein coupled receptor 6 kinase polypeptides

#4235
20140303372
2014-10-09

SULFONYLPYRAZOLE AND SULFONYLPYRAZOLINE CARBOXAMIDINE DERIVATIVES AS 5-HT6 ANTAGONISTS

#4236
20140303170
2014-10-09

Methods of treating CXCR4-expressing cancers

#4237
20140303167
2014-10-09

CDK9 INHIBITORS IN THE TREATMENT OF MIDLINE CARCINOMA

#4238
20140303165
2014-10-09

Substituted pyrimidines as protein kinase inhibitors

#4239
20140303156
2014-10-09

(6-oxo-1,6-dihydropyrimidin-2-yl)amide derivatives, preparation thereof and pharmaceutical use thereof as AKT(PKB) phosphorylation inhibitors

#4240
20140303154
2014-10-09

2,4-pyridinediamine compounds and their uses

#4241
20140303139
2014-10-09

Pyrimidines as sodium channel blockers

#4242
20140302988
2014-10-09

1,2,4-triazolyl-substituted ketoenols

#4243
20140302069
2014-10-09

Modulators of C3a receptors

#4244
20140302010
2014-10-09

Substituted benzimidazoles

#4245
20140296292
2014-10-02

Methods and compositions associated with the granulocyte colony-stimulating factor receptor

#4246
20140296271
2014-10-02

Kinase inhibitor

#4247
20140296268
2014-10-02

Therapeutic methods and compositions involving allosteric kinase inhibition

#4248
20140296221
2014-10-02

Iminothiadiazine dioxide compounds as brace inhibitors, compositions, and their use

#4249
20140296217
2014-10-02

MEDICAMENTS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES

#4250
20140296213
2014-10-02

Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline--dimethylamide

#4251
20140296212
2014-10-02

SUBSTITUTED PHENOXYPROPYLCYCLOAMINE DERIVATIVES AS HISTAMINE-3 (H3) RECEPTOR LIGANDS

#4252
20140296208
2014-10-02

Kinase inhibitors

#4253
20140296206
2014-10-02

Compositions useful for treating disorders related to kit

#4254
20140294962
2014-10-02

Method of preparing polymorphic pure form A of bazedoxifene acetate

#4255
20140294767
2014-10-02

Method of treating HCV infection with a small molecule CHK2 inhibitor

#4256
20140288124
2014-09-25

Arginine methyltransferase inhibitors and uses thereof

#4257
20140288120
2014-09-25

Compounds useful for treating aids

#4258
20140288100
2014-09-25

Galactokinase inhibitors for the treatment and prevention of associated diseases and disorders

#4259
20140288065
2014-09-25

N,N-substituted 3-aminopyrrolidine compounds useful as monoamines reuptake inhibitors

#4260
20140288049
2014-09-25

2-thiopyrimidinones

#4261
20140288048
2014-09-25

Heterocyclic compounds and uses thereof

#4262
20140275711
2014-09-18

1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof

#4263
20140275106
2014-09-18

Combinations of AKT inhibitor compounds and vemurafenib, and methods of use

#4264
20140275105
2014-09-18

CRYSTAL OF ANDROGEN RECEPTOR ANTAGONISTIC COMPOUND

#4265
20140275102
2014-09-18

Solid State Forms of 6-[4-[3-((R)-2-Methylpyrrolidine-1-yl)-propoxy]phenyl] 2H-pyridazine-3-one Hydrochloride

#4266
20140275100
2014-09-18

Substituted pyridazines for the treatment of pain

#4267
20140275087
2014-09-18

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

#4268
20140275086
2014-09-18

Pyrrolidine derivatives, pharmaceutical compositions containing them, and their use in therapy

#4269
20140275079
2014-09-18

Pyrrole-3-carboxamide bromodomain inhibitors

#4270
20140275077
2014-09-18

Uracil derivatives as AXL and c-MET kinase inhibitors

#4271
20140275059
2014-09-18

DNA-PK inhibitors

#4272
20140275029
2014-09-18

1,2,6-substituted benzimidazoles as FLAP modulators

#4273
20140275025
2014-09-18

Substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

#4274
20140275024
2014-09-18

Substituted quinoxaline DNA-PK inhibitors

#4275
20140275003
2014-09-18

Biaryl amide compounds as kinase inhibitors

#4276
20140271662
2014-09-18

Pyrazole derivatives as protein kinase modulators

#4277
20140256736
2014-09-11

Biaryl ether sulfonamides and their use as therapeutic agents

#4278
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#4279
20140256691
2014-09-11

Combinations of AKT inhibitor compounds and abiraterone, and methods of use

#4280
20140255428
2014-09-11

Quinazoline inhibitors of activating mutant forms of epidermal growth factor receptor

#4281
20140249319
2014-09-04

Chemical crosslinkers and compositions thereof

#4282
20140249169
2014-09-04

1-pyrazolyl-3-(4-((2-anilinopyrimidin-4-yl)oxy)napththalen-1-yl) ureas as p38 MAP kinase inhibitors

#4283
20140249151
2014-09-04

Bicyclic heterocyclic compound

#4284
20140249137
2014-09-04

Pyrimidine compounds as tuberculosis inhibitors

#4285
20140249135
2014-09-04

PIM KINASE INHIBITORS AND METHODS OF THEIR USE

#4286
20140249129
2014-09-04

Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

#4287
20140249128
2014-09-04

Triazine carboxamides as sodium channel blockers

#4288
20140248378
2014-09-04

Pyrimidinone compounds and their use

#4289
20140248236
2014-09-04

Tricyclic amino containing compounds for treatment or prevention of symptoms associated with endocrine dysfunction

#4290
20140244027
2014-08-28

Method and apparatus for sorting recycled material

#4291
20140243524
2014-08-28

Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin

#4292
20140243519
2014-08-28

Methods and intermediates for preparing macrolactams

#4293
20140243338
2014-08-28

Phenylpyrazole derivatives as potent ROCK1 and ROCK2 inhibitors

#4294
20140243314
2014-08-28

Quinolinone carboxamide inhibitors of endothelial lipase

#4295
20140243309
2014-08-28

Cycloalkylnitrile pyrazole carboxamides as janus kinase inhibitors

#4296
20140243308
2014-08-28

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

#4297
20140243305
2014-08-28

Azetidinyl diamides as monoacylglycerol lipase inhibitors

#4298
20140239260
2014-08-28

Heterocyclic compound and organic light-emitting diode including the same

#4299
20140235702
2014-08-21

Small molecule inhibitors of Mcl-1 and the uses of thereof

#4300
20140235657
2014-08-21

Therapeutic compounds and uses thereof

#4301
20140235653
2014-08-21

Hydrazide containing nuclear transport modulators and uses thereof

#4302
20140235641
2014-08-21

Pyrazole carboxamides as Janus kinase inhibitors

#4303
20140235622
2014-08-21

Primary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#4304
20140235613
2014-08-21

SUBSTITUTED DIARYL AZETIDINE DERIVATIVES AS SPHINGOSINE RECEPTOR MODULATORS

#4305
20140235606
2014-08-21

CRYSTALLINE FORMS OF N-[2-[[(2,3-DIFLUOROPHENYL)METHYL]THIO]-6--4-PYRIMIDINYL]-1-AZETIDINESULFONAMIDE

#4306
20140234939
2014-08-21

Benzamide compounds and related methods of use

#4307
20140234887
2014-08-21

Fluorogenic peptidase substrate

#4308
20140234333
2014-08-21

Compositions and methods for inhibition of the JAK pathway

#4309
20140228416
2014-08-14

Substituted hydroxamic acids and uses thereof

#4310
20140228383
2014-08-14

Process for the production of moxonidine

#4311
20140228378
2014-08-14

N-(benzimimdazol-2-yl)-cyclopropane carboxamides as lysophosphatidic acid antagonists

#4312
20140228371
2014-08-14

Substituted quinoxalines as sodium channel modulators

#4313
20140228367
2014-08-14

Preparation and methods of use for ortho-aryl 5-membered heteroaryl-carboxamide containing multi-targeted kinase inhibitors

#4314
20140228361
2014-08-14

Aminoquinazoline derivatives and their salts and methods of use

#4315
20140228360
2014-08-14

PRMT5 inhibitors and uses thereof

#4316
20140228358
2014-08-14

Acyclic cyanoethylpyrazoles as janus kinase inhibitors

#4317
20140228348
2014-08-14

Cyanomethylpyrazole carboxamides as janus kinase inhibitors

#4318
20140228342
2014-08-14

Oxazetidine derivatives, process for preparing them and use in human medicine and in cosmetics

#4319
20140228339
2014-08-14

Compound

#4320
20140228321
2014-08-14

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#4321
20140225097
2014-08-14

Stilbene derivatives, light-emitting element, display device, and electronic device

#4322
20140221421
2014-08-07

Therapeutic compounds

#4323
20140221403
2014-08-07

Quinazoline based EGFR inhibitors containing a zinc binding moiety

#4324
20140221396
2014-08-07

Substituted pyrazines as tubulin inhibitors

#4325
20140221391
2014-08-07

Piperazinyl cyclohexane compounds as GPR38 agonists

#4326
20140221386
2014-08-07

Combinations of AKT inhibitor compounds and erlotinib, and methods of use

#4327
20140221376
2014-08-07

Substituted pyridazinecarboxamides as kinase inhibitors

#4328
20140221373
2014-08-07

Arylpyrazole ethers as inhibitors of leukotriene A4 hydrolase

#4329
20140221357
2014-08-07

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#4330
20140221352
2014-08-07

Compositions and methods for inhibition of the JAK pathway

#4331
20140221347
2014-08-07

Therapeutic compounds

#4332
20140221346
2014-08-07

THERAPEUTIC COMPOUNDS

#4333
20140221339
2014-08-07

Heterocyclic derivative and pharmaceutical drug

#4334
20140221337
2014-08-07

Potassium channel blockers

#4335
20140221311
2014-08-07

Flap modulators

#4336
20140221310
2014-08-07

Flap modulators

#4337
20140213788
2014-07-31

PROCESS FOR THE PREPARATION OF ALPHA-ACYLOXY BETA-FORMAMIDO AMIDES

#4338
20140213592
2014-07-31

Protein kinase inhibitors (variants), use thereof in treating oncological diseases and a pharmaceutical composition based thereon

#4339
20140213588
2014-07-31

Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors

#4340
20140213586
2014-07-31

Viral replication inhibitors

#4341
20140213574
2014-07-31

2,4-disubstituted pyrimidines as kinase inhibitors

#4342
20140213570
2014-07-31

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#4343
20140213554
2014-07-31

Compounds and methods for kinase modulation, and indications therefor

#4344
20140212509
2014-07-31

Inhibitors of poly(ADP-ribose)polymerase

#4345
20140206706
2014-07-24

Five-membered heterocycles useful as serine protease inhibitors

#4346
20140206701
2014-07-24

SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF

#4347
20140206694
2014-07-24

Heterocyclic compounds and their uses

#4348
20140206688
2014-07-24

Amino quinazolines as kinase inhibitors

#4349
20140206687
2014-07-24

Quinazoline derivative, preparation method therefor, intermediate, composition and application thereof

#4350
20140206686
2014-07-24

Substituted phthalazinones as rock inhibitors

#4351
20140206675
2014-07-24

Iminothiadiazine dioxide compounds as BACE inhibitors, compositions, and their use

#4352
20140206668
2014-07-24

Pesticidal compositions and processes related thereto

#4353
20140206660
2014-07-24

Phenyl-heteroaryl derivatives and methods of use thereof

#4354
20140206605
2014-07-24

Crystal forms of a HCV protease inhibitor

#4355
20140200343
2014-07-17

Process and intermediates for preparing macrolactams

#4356
20140200245
2014-07-17

Inhibitors of C-FMS kinase

#4357
20140200232
2014-07-17

Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use

#4358
20140194452
2014-07-10

Pyrazolyl-based carboxamides II

#4359
20140194449
2014-07-10

Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof

#4360
20140194439
2014-07-10

Methods of targeted drug development

#4361
20140194425
2014-07-10

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#4362
20140194424
2014-07-10

Spirolactam derivatives and uses of same

#4363
20140187781
2014-07-03

AMINOPYRIDINES AND AMINOPYRIMIDINES USEFUL AS INHIBITORS OF PROTEIN KINASES

#4364
20140187772
2014-07-03

PYRAZOLE COMPOUNDS USEFUL AS PROTEIN KINASE INHIBITORS

#4365
20140187672
2014-07-03

Corrosion-inhibiting microgels and non-chromated primer compositions incorporating the same

#4366
20140187592
2014-07-03

Nitrogen-containing aromatic heterocyclyl compound

#4367
20140187550
2014-07-03

BICYCLIC ORGANIC COMPOUNDS SUITABLE FOR THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS

#4368
20140187543
2014-07-03

Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

#4369
20140187540
2014-07-03

Compounds and methods of use thereof for treating neurodegenerative disorders

#4370
20140187531
2014-07-03

Apoptosis promoters

#4371
20140187529
2014-07-03

Aminopyrazine compounds

#4372
20140179902
2014-06-26

Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof

#4373
20140179718
2014-06-26

Phosphatidylinositol 3-kinase inhibitors

#4374
20140179711
2014-06-26

PROCESS FOR PREPARING 2-AMINOTHIAZOLE-5-AROMATIC CARBOXAMIDES AS KINASE INHIBITORS

#4375
20140179708
2014-06-26

Substituted piperazin-2,5-diones as multifunctional bioactive compounds

#4376
20140179699
2014-06-26

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase

#4377
20140179689
2014-06-26

Rho kinase inhibitors and methods of use

#4378
20140179681
2014-06-26

METHODS AND COMPOSITIONS OF TARGETED DRUG DEVELOPMENT

#4379
20140179673
2014-06-26

Phosphatidylinositol 3-kinase inhibitors

#4380
20140179664
2014-06-26

Heterocyclyl Pyrimidine Analogues As JAK Inhibitors

#4381
20140178360
2014-06-26

Pyrimidine compounds as mTOR and PI3K inhibitors

#4382
20140171639
2014-06-19

TRPM8 antagonists and their use in treatments

#4383
20140171439
2014-06-19

Inhibitors of histone deacetylase

#4384
20140171432
2014-06-19

Histone demethylase inhibitors

#4385
20140171421
2014-06-19

Treating diseases mediated by blockade of the epithelial sodium channel with pyrazine-2-carboxamide derivatives

#4386
20140171404
2014-06-19

Autotaxin inhibitors

#4387
20140171403
2014-06-19

Autotaxin inhibitors

#4388
20140167007
2014-06-19

Pyrene-based compound and organic light-emitting diode including the same

#4389
20140163049
2014-06-12

Antimicrobial compounds and methods of making and using the same

#4390
20140163032
2014-06-12

Ethers, secondary amines and derivatives thereof as modulators of the 5-HTserotonin receptor useful for the treatment of disorders related thereto

#4391
20140162997
2014-06-12

Substituted pyrazoles as N-type calcium channel blockers

#4392
20140162984
2014-06-12

Phosphonoxy quinazoline derivatives and their pharmaceutical use

#4393
20140162983
2014-06-12

Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

#4394
20140161801
2014-06-12

Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof

#4395
20140155599
2014-06-05

Process for the preparation of condensation products of melamine

#4396
20140155447
2014-06-05

Pyrrole inhibitors of S-nitrosoglutathione reductase as therapeutic agents

#4397
20140155418
2014-06-05

Processes for the preparation of substituted quinazolines

#4398
20140155386
2014-06-05

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as axl inhibitors

#4399
20140155377
2014-06-05

3-CYCLOALKYLAMINOPYRROLIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTORS

#4400
20140155370
2014-06-05

Nuclear transport modulators and uses thereof

#4401
20140154772
2014-06-05

Inhibitors of human phosphatidylinositol 3-kinase delta

#4402
20140151661
2014-06-05

Amine derivative, organic electroluminescence material, and organic electroluminescence device including the same

#4403
20140148462
2014-05-29

Indanyloxydihydrobenzofuranylacetic acids

#4404
20140148459
2014-05-29

MATRIX METALLOPROTEINASE INHIBITORS

#4405
20140148448
2014-05-29

Inhibitors of c-fms kinase

#4406
20140148443
2014-05-29

Novel Imidazolines as dual inhibitors of MDM2 and MDMX

#4407
20140148436
2014-05-29

AKT PROTEIN KINASE INHIBITORS

#4408
20140142307
2014-05-22

Azolium and purinium salt anticancer and antimicrobial agents

#4409
20140142147
2014-05-22

Carbocyanines for G-quadruplex DNA stabilization and telomerase inhibition

#4410
20140142114
2014-05-22

Anthelmintic compounds and compositions and method of using thereof

#4411
20140142112
2014-05-22

Therapeutic agents useful for treating pain

#4412
20140142111
2014-05-22

Pyrazole compounds for controlling invertebrate pests

#4413
20140142104
2014-05-22

Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof

#4414
20140142094
2014-05-22

KINASE INHIBITORS

#4415
20140142088
2014-05-22

PYRIDAZINONE DERIVATIVES

#4416
20140142085
2014-05-22

Compounds for the treatment of HIV

#4417
20140142084
2014-05-22

Nitrogen-containing aromatic heterocyclic compound

#4418
20140141099
2014-05-22

DRUG DISCOVERY METHODS

#4419
20140135495
2014-05-15

Stereoselective synthesis of bicyclic heterocycles

#4420
20140135364
2014-05-15

Pesticidal compositions

#4421
20140135341
2014-05-15

Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase

#4422
20140135329
2014-05-15

Pyridine and Pyrazine derivative for the Treatment of CF

#4423
20140135318
2014-05-15

Substituted sulfonamides useful as antiapoptotic Bcl inhibitors

#4424
20140135310
2014-05-15

SULPHONAMIDE DERIVATIVES OF ALICYCLIC AMINES FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

#4425
20140134235
2014-05-15

Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors

#4426
20140128619
2014-05-08

Intermediates useful in the preparation of maleimide functionalized polymers

#4427
20140128550
2014-05-08

4- and 5-substituted 1,2,3-triazole, and regioisomer mixtures thereof, modified polymers

#4428
20140128406
2014-05-08

Microbiocidal heterocycles

#4429
20140128394
2014-05-08

Piperazine compound capable of inhibiting prostaglandin D synthase

#4430
20140128380
2014-05-08

METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR

#4431
20140128376
2014-05-08

Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use

#4432
20140128361
2014-05-08

Cyclic amide BACE-1 inhibitors having a benzamide substituent

#4433
20140128344
2014-05-08

Soft protease inhibitors and pro-soft forms thereof

#4434
20140127273
2014-05-08

Inhibition of bacterial biofilms with imidazole derivatives

#4435
20140124748
2014-05-08

Heterocyclic compound and organic light emitting device including the same

#4436
20140121352
2014-05-01

Reversible pegylated drugs

#4437
20140121195
2014-05-01

Substituted benzimidazoles and benzopyrazoles as CCR(4) antagonists

#4438
20140118816
2014-05-01

Surfactants with a terminal dialkyl- or cycloalkyl-substituted tertiary amine and inks including the same

#4439
20140114064
2014-04-24

P38 MAP kinase inhibitors

#4440
20140113890
2014-04-24

4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

#4441
20140110675
2014-04-24

Compound and organic light emitting device including the same

#4442
20140107156
2014-04-17

Amino azaheterocyclic carboxamides

#4443
20140107128
2014-04-17

Heterocyclic compounds and uses thereof in the treatment of sexual disorders

#4444
20140107125
2014-04-17

HYDRAZONOPYRAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTICS

#4445
20140107120
2014-04-17

Dual-acting benzoimidazole antihypertensive agents

#4446
20140107111
2014-04-17

Use of sigma ligands in diabetes type-2 associated pain

#4447
20140100239
2014-04-10

Quinazolinedione derivatives as PARP inhibitors

#4448
20140100215
2014-04-10

Methods of Using PI3K and MEK Modulators

#4449
20140100214
2014-04-10

Substituted isoquinolinones and methods of treatment thereof

#4450
20140100211
2014-04-10

Pyrrolidine derivatives, pharmaceutical compositions and uses thereof

#4451
20140100210
2014-04-10

Guanidine compound

#4452
20140094608
2014-04-03

Modified carbocyanine dyes and their conjugates

#4453
20140094480
2014-04-03

Pro-neurogenic compounds

#4454
20140094474
2014-04-03

Androgen receptor modulating carboxamides

#4455
20140094471
2014-04-03

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#4456
20140093513
2014-04-03

METHODS OF LOWERING PROPROTEIN CONVERSATE SUBTILISIN/KEXIN TYPE 9 (PCSK9)

#4457
20140088106
2014-03-27

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#4458
20140088097
2014-03-27

Substituted pyrazines and their use in the treatment of disease

#4459
20140088094
2014-03-27

N-sulfonylated tetrahydroquinolines and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease

#4460
20140080835
2014-03-20

Quinazolinone derivatives as PARP inhibitors

#4461
20140080831
2014-03-20

Compounds useful for treating cancer

#4462
20140080829
2014-03-20

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

#4463
20140080828
2014-03-20

Imidazolyl amide compounds and uses related thereto

#4464
20140080826
2014-03-20

Modulators of ATP-binding cassette transporters

#4465
20140080807
2014-03-20

Substituted indazole derivatives active as kinase inhibitors

#4466
20140080802
2014-03-20

Inhibitors of histone deacetylase

#4467
20140080800
2014-03-20

Inhibitors of histone deacetylase

#4468
20140080798
2014-03-20

VEGFR3 inhibitors

#4469
20140079667
2014-03-20

Tetrazolones as inhibitors of fatty acid synthase

#4470
20140073783
2014-03-13

Neprilysin inhibitors

#4471
20140073622
2014-03-13

Imidazole carbonyl compound

#4472
20140073620
2014-03-13

VEGFR3 inhibitors

#4473
20140066623
2014-03-06

Ribosome structure and protein synthesis inhibitors

#4474
20140066621
2014-03-06

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#4475
20140066619
2014-03-06

Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline--dimethylamide

#4476
20140066477
2014-03-06

Benzazole derivatives, compositions, and methods of use as beta-secretase inhibitors

#4477
20140066476
2014-03-06

Modulators of cellular adhesion

#4478
20140066466
2014-03-06

Necroptosis inhibitors and methods of use therefor

#4479
20140066457
2014-03-06

Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases

#4480
20140066455
2014-03-06

NOVEL COMPOUNDS

#4481
20140066448
2014-03-06

Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors

#4482
20140066426
2014-03-06

Fluoromethyl-substituted pyrrole carboxamides

#4483
20140066422
2014-03-06

Phenoxy-substituted pyrimidines as opioid receptor modulators

#4484
20140066420
2014-03-06

Heterocyclic compound

#4485
20140066369
2014-03-06

Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto

#4486
20140058047
2014-02-27

Ionic Viscoelastics and Viscoelastic Salts

#4487
20140057915
2014-02-27

KINASE INHIBITORS

#4488
20140057913
2014-02-27

Aurora kinase inhibitors and methods of making and using thereof

#4489
20140057912
2014-02-27

Pyrimidine-4,6-diamine derivatives as PI3K inhibitors

#4490
20140057911
2014-02-27

4,6-disubstituted aminopyrimidine derivatives have anti-HIV activity

#4491
20140057910
2014-02-27

Heterocyclic aspartyl protease inhibitors

#4492
20140057906
2014-02-27

Modulators of ATP-binding cassette transporters

#4493
20140056880
2014-02-27

TRIAZOLE COMPOUNDS AS KSP INHIBITORS

#4494
20140054561
2014-02-27

Electron transport material and organic electroluminescent device using the same

#4495
20140051857
2014-02-20

HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

#4496
20140051703
2014-02-20

Thiopyrimidine-based compounds and uses thereof

#4497
20140051675
2014-02-20

Modulators of cellular adhesion

#4498
20140051674
2014-02-20

NEW COMPOUNDS

#4499
20140051672
2014-02-20

1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions

#4500
20140045862
2014-02-13

Cycloalkane derivatives